Eurizon Capital SGR SpA’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Eurizon Capital SGR SpA's ELV Position: Q2 2026 in Review
Eurizon Capital SGR SpA reduced its Elevance Health (ELV) stake by 55% in Q2 2026, selling an estimated $30.1M and leaving 67,351 shares worth $26.1M. The position accounts for 0.07% of the portfolio, ranked #218.
Eurizon Capital SGR SpA first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $65.9M in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Eurizon Capital SGR SpA held 67,351 shares of Elevance Health worth $26.1M as of Q2 2026.
- Eurizon Capital SGR SpA sold 81,057 Elevance Health shares in Q2 2026, an estimated $30.1M.
- Elevance Health made up 0.07% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #218 holding.
- Eurizon Capital SGR SpA first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
- Eurizon Capital SGR SpA's Elevance Health position peaked at $65.9M in Q4 2025.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.